Morgan Stanley Starts Portola Pharmaceuticals (PTLA) at Overweight
Tweet
Share
E-mailGet Alerts PTLA Hot Sheet
Price: $18.03 --0%
Rating Summary:
1 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 59
Rating Summary:
1 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 59
Join SI Premium – FREE
Morgan Stanley initiates coverage on Portola Pharmaceuticals (NASDAQ: PTLA) with a Overweight. PT $32.00.
For an analyst ratings summary and ratings history on Portola Pharmaceuticals click here. For more ratings news on Portola Pharmaceuticals click here.
Shares of Portola Pharmaceuticals closed at $20.05 yesterday.
For an analyst ratings summary and ratings history on Portola Pharmaceuticals click here. For more ratings news on Portola Pharmaceuticals click here.
Shares of Portola Pharmaceuticals closed at $20.05 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Starts Inhibrx Biosciences (INBX) at Buy
- Piper Sandler Assumes Veeva Systems (VEEV) at Overweight
- Lucid Capital Markets Starts Insight Molecular Diagnostics Inc. (IMDX) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
